Protective effects of allergic diseases in COVID-19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer

Aida Santaolalla; Heather J Bax; Jitesh Chauhan; Debra H Josephs; Mieke Van Hemelrijck; Sophia N Karagiannis

doi:10.1111/cea.14445

Protective effects of allergic diseases in COVID-19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer

Aida Santaolalla^*, Heather J Bax, Jitesh Chauhan, Debra H Josephs, Mieke Van Hemelrijck, Sophia N Karagiannis

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

84 Downloads (Pure)

Original language	English
Pages (from-to)	297-299
Number of pages	3
Journal	Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Volume	54
Issue number	4
Early online date	16 Jan 2024
DOIs	https://doi.org/10.1111/cea.14445
Publication status	Published - Apr 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/cea.14445Licence: CC BY

Clin Experimental Allergy - 2024 - Santaolalla - Protective effects of allergic diseases in COVID‐19 outcomes AFinal published version, 187 KBLicence: CC BY

Cite this

Santaolalla, A., Bax, H. J., Chauhan, J., Josephs, D. H., Van Hemelrijck, M., & Karagiannis, S. N. (2024). Protective effects of allergic diseases in COVID-19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 54(4), 297-299. https://doi.org/10.1111/cea.14445

@article{fee0903e3134441fa4bc892d63ca2a2a,

title = "Protective effects of allergic diseases in COVID-19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer",

author = "Aida Santaolalla and Bax, {Heather J} and Jitesh Chauhan and Josephs, {Debra H} and {Van Hemelrijck}, Mieke and Karagiannis, {Sophia N}",

note = "Funding Information: The authors acknowledge support by Cancer Research UK (C30122/A11527; C30122/A15774); the Guy's and St Thomas' Foundation Trust Charity Melanoma Special Fund (SPF573); Cancer Research UK King's Health Partners Centre at King's College London (C604/A25135); and Breast Cancer Now (147; KCL‐BCN‐Q3). The research was supported by the National Institute for Health and Care Research Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London and the NIHR Clinical Research Facility (NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, IS‐BRC‐1215‐20006). The authors are solely responsible for the study design, data collection, analysis, decision to publish, and preparation of the article. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. Moreover, we thank all the patients and families that have contributed to this study and to Raphaelle Boulas for the contribution to the data analysis. This research has been conducted using the UK Biobank Resource under Application Number 63317.",

year = "2024",

month = apr,

doi = "10.1111/cea.14445",

language = "English",

volume = "54",

pages = "297--299",

journal = "Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology",

issn = "0954-7894",

publisher = "Blackwell Publishing",

number = "4",

}

Santaolalla, A, Bax, HJ , Chauhan, J , Josephs, DH , Van Hemelrijck, M & Karagiannis, SN 2024, 'Protective effects of allergic diseases in COVID-19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer', Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, vol. 54, no. 4, pp. 297-299. https://doi.org/10.1111/cea.14445

Protective effects of allergic diseases in COVID-19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer. / Santaolalla, Aida; Bax, Heather J ; Chauhan, Jitesh et al.
In: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, Vol. 54, No. 4, 04.2024, p. 297-299.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Protective effects of allergic diseases in COVID-19 outcomes

T2 - A retrospective cohort study in UK Biobank in the general population and in patients with cancer

AU - Santaolalla, Aida

AU - Bax, Heather J

AU - Chauhan, Jitesh

AU - Josephs, Debra H

AU - Van Hemelrijck, Mieke

AU - Karagiannis, Sophia N

N1 - Funding Information: The authors acknowledge support by Cancer Research UK (C30122/A11527; C30122/A15774); the Guy's and St Thomas' Foundation Trust Charity Melanoma Special Fund (SPF573); Cancer Research UK King's Health Partners Centre at King's College London (C604/A25135); and Breast Cancer Now (147; KCL‐BCN‐Q3). The research was supported by the National Institute for Health and Care Research Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London and the NIHR Clinical Research Facility (NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, IS‐BRC‐1215‐20006). The authors are solely responsible for the study design, data collection, analysis, decision to publish, and preparation of the article. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. Moreover, we thank all the patients and families that have contributed to this study and to Raphaelle Boulas for the contribution to the data analysis. This research has been conducted using the UK Biobank Resource under Application Number 63317.

PY - 2024/4

Y1 - 2024/4

UR - http://www.scopus.com/inward/record.url?scp=85182475233&partnerID=8YFLogxK

U2 - 10.1111/cea.14445

DO - 10.1111/cea.14445

M3 - Letter

C2 - 38226782

SN - 0954-7894

VL - 54

SP - 297

EP - 299

JO - Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

JF - Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

IS - 4

ER -

Santaolalla A, Bax HJ , Chauhan J , Josephs DH , Van Hemelrijck M , Karagiannis SN. Protective effects of allergic diseases in COVID-19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2024 Apr;54(4):297-299. Epub 2024 Jan 16. doi: 10.1111/cea.14445

Protective effects of allergic diseases in COVID-19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer

UN SDGs

Access to Document

Other files and links

Cite this